Brian Culley

R&D

Lineage Cell Therapeutics' Brian Culley discusses allogeneic cell therapy, even beyond the traditional cell therapy realm of oncology.

News

Merck KGaA has started working with Remepy on the development of hybrid drugs that combine medicines with digital therapeutics.

Sales & Marketing

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.